1. Should a third booster dose be scheduled after two doses of CoronaVac? A single-center experience.
- Author
-
Yigit M, Ozkaya-Parlakay A, Cosgun Y, Ince YE, Bulut YE, and Senel E
- Subjects
- Adult, Aged, COVID-19 immunology, Coronavirus Nucleocapsid Proteins immunology, Female, Health Personnel statistics & numerical data, Humans, Immunization Schedule, Immunoglobulin G blood, Male, Middle Aged, Phosphoproteins immunology, Retrospective Studies, Seroconversion physiology, Turkey, Vaccines, Inactivated immunology, Vaccines, Synthetic immunology, Young Adult, Antibodies, Neutralizing blood, Antibodies, Viral blood, COVID-19 prevention & control, COVID-19 Vaccines immunology, Immunization, Secondary methods, SARS-CoV-2 immunology
- Abstract
In the 10th month of the pandemic, coronavirus disease 2019 (COVID-19) vaccination was given first to healthcare workers in Turkey after receiving emergency use approval from the Ministry of Health. This study, which was performed at the COVID-19 reference center in Ankara (the capital of Turkey) aimed to evaluate the seroconversion rate of the CoronaVac vaccine. The anti-spike immunoglobulin G response to the two-dose vaccination was retrospectively examined in healthcare workers who had no previous history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The postvaccine seroconversion rate was investigated by measuring the antibody levels of healthcare workers who had received CoronaVac. Vaccination was administered as 600 SU in 28-day intervals. The healthcare workers' anti-SARS-CoV-2 immunoglobulin G levels were used to determine the seroconversion rate 2 months after the second dose of the vaccine. Of the healthcare workers, 22.9% (n = 155) were seronegative. The younger the age of the participant, the higher the level of anti-SARS-CoV-2 immunoglobulin G. Furthermore, anti-SARS-CoV-2 immunoglobulin G levels were much higher in women than men., (© 2021 Wiley Periodicals LLC.)
- Published
- 2022
- Full Text
- View/download PDF